Articulos

Effectiveness and safety of dexamphetamine sulfate (Attentin® ) in the routine treatment of children and adolescents with ADHD: results from a 12-month non-interventional study

Henrik Uebel-von Sandersleben , Oliver Dangel, Roland Fischer, Michaela Ruhmann, Michael Huss

Uebel-von Sandersleben H et al. Scand J Child Adolesc Psychiatr Psychol. 2021;9:73-86.

Más información

ADHD drug treatment and risk of suicidal behaviours, substance misuse, accidental injuries, transport accidents, and criminality: emulation of target trials

Le Zhang, Nanbo Zhu, Arvid Sjölander, et al.

BMJ. 2025 Aug 13:390:e083658. doi: 10.1136/bmj-2024-083658.

Más información

Life expectancy and years of life lost for adults with diagnosed ADHD in the UK: matched cohort study.

O'Nions E, El Baou C, John A, Lewer D, Mandy W, McKechnie DGJ, Petersen I, Stott J.

Br J Psychiatry. 2025 Jan 23;226(5):1-8. doi: 10.1192/bjp.2024.199. Epub ahead of print. PMID: 39844532; PMCID: PMC7617439.

Más información

Comparative efficacy and acceptability of pharmacological, psychological, and neurostimulatory interventions for ADHD in adults: a systematic review and component network meta-analysis.

Ostinelli EG, Schulze M, Zangani C, Farhat LC, Tomlinson A, Del Giovane C, Chamberlain SR, Philipsen A, Young S, Cowen PJ, Bilbow A, Cipriani A, Cortese S.

Lancet Psychiatry. 2025 Jan;12(1):32-43. doi: 10.1016/S2215-0366(24)00360-2. PMID: 39701638.

Más información